DB Stock Recent News
DB LATEST HEADLINES
Deutsche Bank has reiterated its 'buy' rating on Creo Medical Group PLC (AIM:CREO) with a price target of 40p following the company's full-year results on Monday. The target implies a near fourfold increase from the current share price of just over 10p.
Future PLC (LSE:FUTR) results met expectations, but Deutsche Bank analysts cut their target price slightly. Revenue for the first quarter of the year declined 1% organically, with growth offset by macroeconomic uncertainty in the US, which impacted advertising revenue in March.
Deutsche Bank analyst George Hill joins ‘Closing Bell Overtime' to discuss why he maintains his buy ratings on UnitedHealth Group despite the stock heading for its worst month ever.
DB's robust earnings and aggressive capital distribution plan look encouraging. Read on to know if it is worth buying now.
Deutsche Bank has asked the European Central Bank for permission to conduct a share buyback in the second half of 2025, chief executive Christian Sewing said in a speech published on Thursday.
David Bianco, DWS Group Americas CIO, joins CNBC's 'Money Movers' to discuss market outlooks for the summer.
US stocks have staged a bit of a comeback lately, but Deutsche Bank is not convinced the rally has legs, at least not compared to Europe. In a fresh note, the bank argues that the outlook for European equities still looks brighter on several fronts, despite the S&P 500's recent outperformance.
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
It's been a wild year for the benchmark S&P 500 (^GSPC -0.07%) . The index started the year on a high note and then got crushed, mainly due to concerns about U.S. President Donald Trump's tariffs.